{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3266"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3266","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Air-Jet Bioprinting of Stem Cell-Encapsulated Alginate Micro-Droplets for Organoid Biomanufacturing","abstract":"Biomanufactured 3D-organoids show promise for modeling and treating various conditions, particularly insulin-dependent diabetes mellitus (type-1 diabetes). Pancreatic islet organoids serve as sustainable sources of insulin-producing β-cells, potentially restoring insulin regulation in patients and providing a long-term solution for diabetes. Hydrogel droplet printing is an emerging technique in regenerative medicine due to its advantageous tunability and biocompatibility; however, challenges of consistency, quality control, and scalability persist. To address these issues, we developed a novel air-jetting based droplet bioprinting system for the generation of monodispersed alginate micro-droplets. The objective of this project was to incorporate human induced pluripotent stem cells (hiPSCs) into these micro-droplets while maintaining uniformity, size, viability, and functionality. Comprehensive parametric studies led to the standardization of our process for the scalable production of spherical stem cell-laden micro-droplets within a customizable size range (300-650μm). Ongoing investigations into cell seeding density, aggregation, and pluripotency will enhance our role of cell encapsulation in the organoid generation pipeline. Herein, we aim to improve the scalability and quality control of bioprinting stem cell-laden micro-droplets to facilitate the manufacturing of suitable organoids for islet transplantation.","abstract_html":"Biomanufactured 3D-organoids show promise for modeling and treating various conditions, particularly insulin-dependent diabetes mellitus (type-1 diabetes). Pancreatic islet organoids serve as sustainable sources of insulin-producing β-cells, potentially restoring insulin regulation in patients and providing a long-term solution for diabetes. Hydrogel droplet printing is an emerging technique in regenerative medicine due to its advantageous tunability and biocompatibility; however, challenges of consistency, quality control, and scalability persist. To address these issues, we developed a novel air-jetting based droplet bioprinting system for the generation of monodispersed alginate micro-droplets. The objective of this project was to incorporate human induced pluripotent stem cells (hiPSCs) into these micro-droplets while maintaining uniformity, size, viability, and functionality. Comprehensive parametric studies led to the standardization of our process for the scalable production of spherical stem cell-laden micro-droplets within a customizable size range (300-650μm). Ongoing investigations into cell seeding density, aggregation, and pluripotency will enhance our role of cell encapsulation in the organoid generation pipeline. Herein, we aim to improve the scalability and quality control of bioprinting stem cell-laden micro-droplets to facilitate the manufacturing of suitable organoids for islet transplantation.","abstract_has_math":false,"creators":["Stump, Mirabella B"],"institution":null,"degree_name":"MS","degree_level":"One-year Embargo","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":["Bin Yang","Kimberly Williams","Kyle Selcer","Ipsita Banerjee"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:32Z","subjects":["Organoid","Pluripotent Stem Cell","Alginate","Air-jetting Bioprinting","Cell Encapsulation","Type-1 Diabetes","3D Stem Cell Culture","Tissue Engineering","Droplet based Bioprinting","Hydrogel","Coaxial Air Channel","Biochemical and Biomolecular Engineering","Biochemistry","Biological Engineering","Biology and Biomimetic Materials","Biomaterials","Biomechanical Engineering","Biomechanics","Biomechanics and Biotransport","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Biotechnology","Cell Biology","Cellular and Molecular Physiology","Chemical Engineering","Disease Modeling","Endocrine System Diseases","Endocrinology","Endocrinology, Diabetes, and Metabolism","Equipment and Supplies","Laboratory and Basic Science Research","Medical Biotechnology","Molecular, Cellular, and Tissue Engineering","Other Rehabilitation and Therapy","Pathology","Polymer and Organic Materials","Quality Improvement","Translational Medical Research"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2293","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2293","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3266","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Bin Yang","Kimberly Williams","Kyle Selcer","Ipsita Banerjee"]},{"key":"dc:creator","label":"Author","values":["Stump, Mirabella B"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-12-31T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-12-15T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["One-year Embargo"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Organoid","Pluripotent Stem Cell","Alginate","Air-jetting Bioprinting","Cell Encapsulation","Type-1 Diabetes","3D Stem Cell Culture","Tissue Engineering","Droplet based Bioprinting","Hydrogel","Coaxial Air Channel","Biochemical and Biomolecular Engineering","Biochemistry","Biological Engineering","Biology and Biomimetic Materials","Biomaterials","Biomechanical Engineering","Biomechanics","Biomechanics and Biotransport","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Biotechnology","Cell Biology","Cellular and Molecular Physiology","Chemical Engineering","Disease Modeling","Endocrine System Diseases","Endocrinology","Endocrinology, Diabetes, and Metabolism","Equipment and Supplies","Laboratory and Basic Science Research","Medical Biotechnology","Molecular, Cellular, and Tissue Engineering","Other Rehabilitation and Therapy","Pathology","Polymer and Organic Materials","Quality Improvement","Translational Medical Research"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2293"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Biomanufactured 3D-organoids show promise for modeling and treating various conditions, particularly insulin-dependent diabetes mellitus (type-1 diabetes). Pancreatic islet organoids serve as sustainable sources of insulin-producing β-cells, potentially restoring insulin regulation in patients and providing a long-term solution for diabetes. Hydrogel droplet printing is an emerging technique in regenerative medicine due to its advantageous tunability and biocompatibility; however, challenges of consistency, quality control, and scalability persist. To address these issues, we developed a novel air-jetting based droplet bioprinting system for the generation of monodispersed alginate micro-droplets. The objective of this project was to incorporate human induced pluripotent stem cells (hiPSCs) into these micro-droplets while maintaining uniformity, size, viability, and functionality. Comprehensive parametric studies led to the standardization of our process for the scalable production of spherical stem cell-laden micro-droplets within a customizable size range (300-650μm). Ongoing investigations into cell seeding density, aggregation, and pluripotency will enhance our role of cell encapsulation in the organoid generation pipeline. Herein, we aim to improve the scalability and quality control of bioprinting stem cell-laden micro-droplets to facilitate the manufacturing of suitable organoids for islet transplantation."]},{"key":"dc:title","label":"Title","values":["Air-Jet Bioprinting of Stem Cell-Encapsulated Alginate Micro-Droplets for Organoid Biomanufacturing"]}]}],"canonical_facts":{"dc:contributor":["Bin Yang","Kimberly Williams","Kyle Selcer","Ipsita Banerjee"],"dc:creator":["Stump, Mirabella B"],"dc:date.available":["2024-12-31T08:00:00Z"],"dc:date.created":["2023-12-15T08:00:00Z"],"dc:description.abstract":["Biomanufactured 3D-organoids show promise for modeling and treating various conditions, particularly insulin-dependent diabetes mellitus (type-1 diabetes). Pancreatic islet organoids serve as sustainable sources of insulin-producing β-cells, potentially restoring insulin regulation in patients and providing a long-term solution for diabetes. Hydrogel droplet printing is an emerging technique in regenerative medicine due to its advantageous tunability and biocompatibility; however, challenges of consistency, quality control, and scalability persist. To address these issues, we developed a novel air-jetting based droplet bioprinting system for the generation of monodispersed alginate micro-droplets. The objective of this project was to incorporate human induced pluripotent stem cells (hiPSCs) into these micro-droplets while maintaining uniformity, size, viability, and functionality. Comprehensive parametric studies led to the standardization of our process for the scalable production of spherical stem cell-laden micro-droplets within a customizable size range (300-650μm). Ongoing investigations into cell seeding density, aggregation, and pluripotency will enhance our role of cell encapsulation in the organoid generation pipeline. Herein, we aim to improve the scalability and quality control of bioprinting stem cell-laden micro-droplets to facilitate the manufacturing of suitable organoids for islet transplantation."],"dc:identifier":["https://dsc.duq.edu/etd/2293"],"dc:language":["English"],"dc:subject":["Organoid","Pluripotent Stem Cell","Alginate","Air-jetting Bioprinting","Cell Encapsulation","Type-1 Diabetes","3D Stem Cell Culture","Tissue Engineering","Droplet based Bioprinting","Hydrogel","Coaxial Air Channel","Biochemical and Biomolecular Engineering","Biochemistry","Biological Engineering","Biology and Biomimetic Materials","Biomaterials","Biomechanical Engineering","Biomechanics","Biomechanics and Biotransport","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Biotechnology","Cell Biology","Cellular and Molecular Physiology","Chemical Engineering","Disease Modeling","Endocrine System Diseases","Endocrinology","Endocrinology, Diabetes, and Metabolism","Equipment and Supplies","Laboratory and Basic Science Research","Medical Biotechnology","Molecular, Cellular, and Tissue Engineering","Other Rehabilitation and Therapy","Pathology","Polymer and Organic Materials","Quality Improvement","Translational Medical Research"],"dc:title":["Air-Jet Bioprinting of Stem Cell-Encapsulated Alginate Micro-Droplets for Organoid Biomanufacturing"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["One-year Embargo"],"thesis:degree_name":["MS"]},"updated_at":"2026-11-19T07:52:32Z"}